Actively Recruiting
Study on Safety and Effectiveness of Short-Term Dual Antiplatelet Therapy After GENOSS DES Stent Placement in Coronary Artery Disease Patients
Led by Genoss Co., Ltd. · Updated on 2025-02-21
1000
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety and effectiveness of a short duration of dual antiplatelet therapy DAPT after implantation of the GENOSS4 drug-eluting stent DES in patients with coronary artery disease. This prospective, multicenter, observational study aims to provide real-world data since previous studies on the GENOSS DES have not fully examined clinical outcomes in routine practice. The study focuses on patients who have received the GENOSS DES and monitors important heart-related events over time. Participants in this study receive the GENOSS DES, a new type of coronary stent made from cobalt-chromium with a biodegradable polymer coating that releases sirolimus. The study observes the outcomes of a short DAPT regimen, lasting three months for patients with stable coronary artery disease and six months for those with acute coronary syndrome. The study is conducted at six sites in South Korea and does not involve randomization or placebo treatments. During the study, participants will be followed for at least 12 months after the stent procedure. Researchers will assess a device-oriented composite endpoint, including cardiac death, target vessel-related heart attacks, and repeat procedures on the treated artery. They will also review a patient-oriented composite endpoint covering all-cause deaths, any heart attacks, and any revascularization procedures. Safety and success of the stent procedure are monitored, along with other secondary outcomes. Participants will undergo clinical follow-up visits to track these events.
CONDITIONS
Brief Title
Efficacy and Safety of Short Duration of DAPT After GENOSS® DES Implantation in Patients with Coronary Artery Disease
Research Team
Y
YoungJin Youn
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here